Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Eur Acad Dermatol Venereol
Main Authors: Ring, J., Worm, M., Wollenberg, A., Thyssen, J.P., Jakob, T., Klimek, L., Bangert, C., Barbarot, S., Bieber, T., de Bruin‐Weller, M.S., Chernyshov, P.V., Christen‐Zaech, S., Cork, M., Darsow, U., Flohr, C., Fölster‐Holst, R., Gelmetti, C., Gieler, U., Gutermuth, J., Heratizadeh, A., Hijnen, D.J., von Kobyletzki, L.B., Kunz, B., Paul, C., De Raeve, L., Seneschal, J., Simon, D., Spuls, P.I., Stalder, J.F., Svensson, A., Szalai, Z., Taieb, A., Torrelo, A., Trzeciak, M., Vestergaard, C., Werfel, T., Weidinger, S., Deleuran, M.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2021
Teme:
Covid‐19 Special Forum
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250791/
https://ncbi.nlm.nih.gov/pubmed/33752263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.17237
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki